Angong Niuhuang Wan inhibit ferroptosis on ischemic and hemorrhagic stroke by activating PPARγ/AKT/GPX4 pathway

Angong Niuhuang Wan (AGNHW) is a prescription from traditional Chinese medicine (TCM) that has been used for centuries to treat ischemic stroke (IS) and hemorrhagic stroke (HS). According to a recent study, targeting ferroptosis might be effective in the management of IS and HS. However, the ferropt...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of ethnopharmacology 2024-03, Vol.321, p.117438-117438, Article 117438
Hauptverfasser:	Bai, Xue, Zheng, Enqi, Tong, Lin, Liu, Yang, Li, Xianyu, Yang, Hong, Jiang, Jie, Chang, Zhenghui, Yang, Hongjun
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Ferroptosis Hemorrhagic Stroke Ischemic Stroke - drug therapy Molecular Docking Simulation Phosphatidylinositol 3-Kinases PPAR gamma Proto-Oncogene Proteins c-akt Rats
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!